These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 3264794)
1. Does the basal lamina contain interleukin 2 receptors? Observations in emerging psoriasis vulgaris lesions. Laub R; Fiebig H; Wohlrab W; Taube KM Dermatol Monatsschr; 1988; 174(6):308-11. PubMed ID: 3264794 [No Abstract] [Full Text] [Related]
2. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. Menssen A; Trommler P; Vollmer S; Schendel D; Albert E; Gürtler L; Riethmüller G; Prinz JC J Immunol; 1995 Oct; 155(8):4078-83. PubMed ID: 7561119 [TBL] [Abstract][Full Text] [Related]
3. In vitro culture of skin-homing T lymphocytes from inflammatory skin diseases. Bang K; Lund M; Mogensen SC; Thestrup-Pedersen K Exp Dermatol; 2005 May; 14(5):391-7. PubMed ID: 15854134 [TBL] [Abstract][Full Text] [Related]
4. Analysis of T cell receptor alpha-chain variable region (Valpha) usage and CDR3alpha of T cells infiltrated into lesions of psoriasis patients. Hwang HY; Kim TG; Kim TY Mol Immunol; 2006 Feb; 43(5):420-5. PubMed ID: 16337484 [TBL] [Abstract][Full Text] [Related]
6. Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in psoriasis vulgaris. Chen L; Shen Z; Wang G; Fan P; Liu Y J Dermatol Sci; 2008 Sep; 51(3):200-3. PubMed ID: 18562180 [No Abstract] [Full Text] [Related]
7. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203 [TBL] [Abstract][Full Text] [Related]
8. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306 [TBL] [Abstract][Full Text] [Related]
9. Targeting interleukin-2 as a treatment for psoriasis. Salim A; Emerson R Curr Opin Investig Drugs; 2001 Nov; 2(11):1546-8. PubMed ID: 11763155 [TBL] [Abstract][Full Text] [Related]
10. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity. Horrocks C; Holder JE; Berth-Jones J; Camp RD Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325 [TBL] [Abstract][Full Text] [Related]
11. Natural killer and natural killer-T cells in psoriasis. Cameron AL; Kirby B; Fei W; Griffiths CE Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. Yawalkar N; Tscharner GG; Hunger RE; Hassan AS J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456 [TBL] [Abstract][Full Text] [Related]
13. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496 [TBL] [Abstract][Full Text] [Related]
14. Subpopulations of mononuclear cells in lesions of psoriasis, lichen planus and discoid lupus erythematosus studied using monoclonal antibodies. Bjerke JR Acta Derm Venereol; 1982; 62(6):477-83. PubMed ID: 6187151 [TBL] [Abstract][Full Text] [Related]
15. In situ characterization and counting of mononuclear cells in lesions of different clinical forms of psoriasis. Bjerke JR Acta Derm Venereol; 1982; 62(2):93-100. PubMed ID: 6179355 [TBL] [Abstract][Full Text] [Related]
16. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Atochina O; Harn D Exp Dermatol; 2006 Jun; 15(6):461-8. PubMed ID: 16689863 [TBL] [Abstract][Full Text] [Related]
17. Characterization of lesional psoriatic skin T lymphocyte clones. Barna M; Snijdewint FG; van der Heijden FL; Bos JD; Kapsenberg ML Acta Derm Venereol Suppl (Stockh); 1994; 186():9-11. PubMed ID: 8073850 [TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. Campanelli AP; Roselino AM; Cavassani KA; Pereira MS; Mortara RA; Brodskyn CI; Goncalves HS; Belkaid Y; Barral-Netto M; Barral A; Silva JS J Infect Dis; 2006 May; 193(9):1313-22. PubMed ID: 16586370 [TBL] [Abstract][Full Text] [Related]
19. [Adenovirus antigens in the cells of affected skin and immunohistochemical shifts in psoriasis]. Vartazarian ND Arkh Patol; 1984; 46(8):45-50. PubMed ID: 6093745 [TBL] [Abstract][Full Text] [Related]
20. Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin. Matsumura Y; Hori T; Nishigori C; Shirogane K; Toda KI; Uchiyama T; Tanaka Y; Miyachi Y Arch Dermatol Res; 2003 Mar; 294(12):563-6. PubMed ID: 12624783 [No Abstract] [Full Text] [Related] [Next] [New Search]